ORCL 8.29SHOP.TO 4.45CDNS -1.795BRK.B 2.89ARGT -1.1IBIT 2.56HPE 2.61SNOW 50.63
Daily Stock Opinions and Ratings
Stockchase Opinions

David BurrowsGenentechDNABUYJul 13, 2005

The biotech sector is one of the first growth oriented groups that turned up and has been relatively strong all year. Likes this one because it has a diversified revenue line. Growing cash flow.
David BurrowsDavid Burrows
Owned
Unlock Rating
$86.65

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist
Track your Stocks in your Watch List

You might be interested:

HOLD

Genentech(DNA)

Jul 21, 2008
Once a takeover bid comes in, it no longer trades on fundamentals. If you already own, keep the stock and wait to see what happens. You could take a bit of profit here.
Photo of Norman LevineNorman LevineUnlock Rating
$93.88

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Genentech(DNA)

Jun 21, 2007
The model price is $48.70, a negative 35% differential. Would choose Amgen (AMGN-Q), which he owns.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$75.97

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Genentech(DNA)

Jun 07, 2007
One of the largest bio-tech firms in the world. He thinks there is not enough control, in knowing how research is going to be able to proceed. (phase 1 through phase 6). Instead he uses PBE-A which is a portfolio. Less exciting but more rewarding long term.
Photo of Charles LannonCharles Lannon
No
Unlock Rating
$74.90

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Genentech(DNA)

May 24, 2005
Model price is $25.24. Very expensive.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$78.60

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Genentech(DNA)

Aug 29, 2001
Growing revenue profits annually 25%. Good products. Good value at this price.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$47.25

Stock price when the opinion was issued

$6.95

As of Sep 03, 2026. Market Open.

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

NOW 8.87$145.59
UBER -0.49$75.96
PLTR 13.07$182.53
HON 1.56$207.63
TSLA 19.355$376.365

Today's Top Picks

ORCL 8.29$154.04
SHOP.TO 4.45$200.96
CDNS -1.795$304.875
BRK.B 2.89$508.13
ARGT -1.1$96.8

Popular Articles

Latest Sell Signals

ZQQ.TO 2.25$198.76
SOXX 0.76$502.2
AAPL 3.25$328.21
ATAI -0.01$7.34
AVAV 1.82$147.21

Most Recent Experts

Kim Bolton

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Dan Rohinton

Dan Rohinton

iA Global Asset Management

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica